chartexchange

PCSA
Processa Pharmaceuticals, Inc. Common
stockNASDAQ

At CloseOct 9, 2026 3:59:50 PM EDT
1.48USD+9.259%(+0.13)2,946,418
1.1800Bid1.4700Ask0.2900Spread
Pre-marketOct 9, 2026 9:28:30 AM EDT
1.3112USD-2.874%(-0.0388)
After-hoursOct 9, 2026 4:43:30 PM EDT
1.40USD-5.085%(-0.08)
Loading…
Loading…
Healthcare
Biotechnology
HQ
Hanover, MD, USA
Previous Close
$1.35
Beta
1.32
52-Week High
$11.08 2025-10-13
52-Week Low
$1.32 2026-10-08
SMA 50
$2.02
SMA 200
$2.49
Avg. Vol 10D
20,668
Avg. Vol 30D
22,977
Avg. Vol 90D
178,794
Relative Vol
121.61
2.34M
10.9500%
1,853
Nov 5, 2026 (27d)
Dec 17, 2025 · 1-for-25 (reverse)
PCSA Profile

processa pharmaceuticals was founded in october 2017 with a mission to develop products that can improve the survival and/or quality of life for patients who have a high unmet medical need. the company is headquartered in hanover, maryland.

PCSA Performance
PeriodPriceDateChangeBeta
1W1.612026-10-02-9.32%2.320
1M1.992026-09-09-26.63%1.951
3M1.972026-07-09-25.89%2.599
6M2.972026-04-09-50.84%2.880
1Y9.822025-10-09-85.13%1.320
2Y31.752024-10-09-95.40%—
5Y3,850.002021-10-08-99.96%0.471
PCSA Stock Summary

Processa Pharmaceuticals, Inc. Common (NASDAQ:PCSA) stock price today is $1.46, and today's volume is 2,794,322. PCSA is up 8.148% today. The 30 day average volume is 22,977. PCSA market cap is $4.08M with 2.79M shares outstanding.